Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Faron Pharmaceuticals Share News (FARN)
FARN Share
Price
FARN Share
News
FARN Share
Chat
FARN Share
Trades
FARN
Live RNS
FARN Share
Charts
FARN Level 2
Console
FARN Live
Share Price
FARN Broker
Ratings
FARN Directors
Deals
FARN Financial
Diary
FARN
Fundamentals
FARN Short
Positions
FARN
Media
FARN Company
Research
FARN Company
Timeline
Share Price Information for Faron Pharmaceuticals (FARN)
Last checked at -
Last checked at 
Intraday Faron Pharmaceuticals Share Chart
Faron Pharmaceuticals Notes Study Supporting Clevegen Programme
LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said an article published in the Journal of Immunology has outlined the functional role of the company's Clever-1 treatment, part of its Clevegen cancer immunotherapy antibody programme.
Faron, which floated in London earlier this month, said the data published in the study supported Clever-1 as an immuosuppresive molecule and supports the use of Clevegen as an immunotherapy product.
"We are working hard to advance our Clevegen programme, as announced recently, towards clinical use as a new onco-immunological alternative," said Faron Chief Executive Markku Jalkanen.
Shares in Faron were trading flat at 275.00 pence on Monday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Latest FARN News
- TRADING UPDATES: Tungsten West 'largest Western tungsten producer'
16 Jan 2023 - Faron Pharmaceuticals sees patient remission in immunotherapy trials
5 Dec 2022 - TRADING UPDATES: Renalytix hails trial results; Kingswood buys JFP
1 Dec 2022 - TRADING UPDATES: Joules nomad resigns; Pharma C loss narrows
18 Nov 2022 - TRADING UPDATES: 4Global wins deal; James Cropper profit warning
31 Oct 2022 - Faron Pharmaceuticals shares down as raises EUR8.4 million in placing
14 Oct 2022 - TRADING UPDATES: Bidstack names new COO; Fintel expands deal
13 Oct 2022 - REPEAT: Faron Pharma half-year loss widens on higher R&D spending
25 Aug 2022
Related News
IN BRIEF: Faron Pharmaceuticals fined EUR30,000 by Nasdaq Helsinki
Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Says the Disciplinary Committee of Nasdaq Helsinki Ltd has imposed an EUR30,0...
WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
Faron Pharmaceuticals News
TRADING UPDATES: Tungsten West 'largest Western tungsten producer'
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Faron Pharmaceuticals sees patient remission in immunotherapy trials
(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it was encouraged by promising early data from trials for its investigative precision immun...
TRADING UPDATES: Renalytix hails trial results; Kingswood buys JFP
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
TRADING UPDATES: Joules nomad resigns; Pharma C loss narrows
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
TRADING UPDATES: 4Global wins deal; James Cropper profit warning
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Faron Pharmaceuticals shares down as raises EUR8.4 million in placing
(Alliance News) - Faron Pharmaceuticals Ltd shares declined on Friday, after it said it has raised EUR8.4 million from a share placing.
TRADING UPDATES: Bidstack names new COO; Fintel expands deal
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
REPEAT: Faron Pharma half-year loss widens on higher R&D spending
(Alliance News) - Faron Pharmaceuticals Ltd on Thursday said its interim loss widened, as the company reported higher research and administrative expe...
Follow the stocks
